Product Name | Fexinidazole (HOE 239) |
---|---|
CAS | 59729-37-2 |
Formula | C12H13N3O3S |
MW | 279.31 |
Appearance | Light yellow to yellow powder |
Storage condition | Dry, dark and at 0 - 4 ℃ for short term (days to weeks) or -20 ℃ for long term (months to years). |
Size | Availability | Price(USD) | VIP Price (USD) | Quantity |
---|---|---|---|---|
5 mg | 3-5days | ¥300.00 | Visible after login | |
10 mg | 3-5days | ¥500.00 | Visible after login | |
25 mg | 3-5days | ¥800.00 | Visible after login |
Product Name | Fexinidazole (HOE 239) |
---|---|
CAS | 59729-37-2 |
Formula | C12H13N3O3S |
MW | 279.31 |
Appearance | Light yellow to yellow powder |
Storage condition | Dry, dark and at 0 - 4 ℃ for short term (days to weeks) or -20 ℃ for long term (months to years). |
Fexinidazole (Hoe239; Hoe-239) is a novel, potent and nitroimidazole-based antiparasitic agent that has been approved in 2021 by FDA as the first all-oral medication to treat African trypanosomiasis caused by Trypanosoma brucei gambiense. It acts well against diseases in both their initial and advanced stages. Its use in Chagas disease is also supported by some evidence.